Close

Core Laboratories (CLB) Misses Q2 EPS by 2c

July 28, 2021 5:16 PM EDT

Core Laboratories (NYSE: CLB) reported Q2 EPS of $0.18, $0.02 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $118.7 million versus the consensus estimate of $119.38 million.

GUIDANCE:

Core Laboratories sees Q3 2021 EPS of $0.19-$0.21, versus the consensus of $0.23.

For earnings history and earnings-related data on Core Laboratories (CLB) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings